CERIBELL INC (CBLL) Stock Overview
NASDAQ:CBLL - US15678C1027 - Common Stock
CBLL Key Statistics, Chart & Performance
The current stock price of CBLL is 11.83 USD. In the past month the price decreased by -16.34%.
CBLL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.07 | 230.89B | ||
| ISRG | INTUITIVE SURGICAL INC | 58.79 | 169.67B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.28 | 156.32B | ||
| SYK | STRYKER CORP | 30.46 | 149.64B | ||
| MDT | MEDTRONIC PLC | 16.78 | 119.05B | ||
| BDX | BECTON DICKINSON AND CO | 13.52 | 55.31B | ||
| IDXX | IDEXX LABORATORIES INC | 53.88 | 51.77B | ||
| EW | EDWARDS LIFESCIENCES CORP | 31.65 | 47.75B | ||
| RMD | RESMED INC | 28.74 | 40.19B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.82 | 33.66B | ||
| DXCM | DEXCOM INC | 44.32 | 29.55B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.42 | 26.56B |
Related stock screener links
About CBLL
Company Profile
Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. The company is headquartered in Sunnyvale, California and currently employs 281 full-time employees. The company went IPO on 2024-10-11. The firm has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
Company Info
CERIBELL INC
360 N. Pastoria Avenue
Sunnyvale CALIFORNIA US
Employees: 281
Phone: 18004360826
CERIBELL INC / CBLL FAQ
What is the stock price of CERIBELL INC today?
The current stock price of CBLL is 11.83 USD. The price decreased by -1.17% in the last trading session.
What is the ticker symbol for CERIBELL INC stock?
The exchange symbol of CERIBELL INC is CBLL and it is listed on the Nasdaq exchange.
On which exchange is CBLL stock listed?
CBLL stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for CERIBELL INC stock?
13 analysts have analysed CBLL and the average price target is 32.44 USD. This implies a price increase of 174.18% is expected in the next year compared to the current price of 11.83. Check the CERIBELL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CERIBELL INC worth?
CERIBELL INC (CBLL) has a market capitalization of 433.69M USD. This makes CBLL a Small Cap stock.
How many employees does CERIBELL INC have?
CERIBELL INC (CBLL) currently has 281 employees.
What are the support and resistance levels for CERIBELL INC (CBLL) stock?
CERIBELL INC (CBLL) has a support level at 11.15 and a resistance level at 12.23. Check the full technical report for a detailed analysis of CBLL support and resistance levels.
Is CERIBELL INC (CBLL) expected to grow?
The Revenue of CERIBELL INC (CBLL) is expected to grow by 34.92% in the next year. Check the estimates tab for more information on the CBLL EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CERIBELL INC (CBLL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CBLL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CBLL, evaluating the profitability, health, valuation and growth aspects
- CERIBELL INC (CBLL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CERIBELL INC (CBLL) Sales and EPS estimates to see what analysts future expectations are.
- CERIBELL INC (CBLL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CERIBELL INC (CBLL) Insider and Institutional Ownership to learn about the owners and their transactions.
- CERIBELL INC (CBLL) Stock Chart to make your own analysis
- CERIBELL INC (CBLL) Latest news and press-releases to stay up to date.
Does CERIBELL INC (CBLL) stock pay dividends?
CBLL does not pay a dividend.
When does CERIBELL INC (CBLL) report earnings?
CERIBELL INC (CBLL) will report earnings on 2025-11-10.
What is the Price/Earnings (PE) ratio of CERIBELL INC (CBLL)?
CERIBELL INC (CBLL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.99).
What is the Short Interest ratio of CERIBELL INC (CBLL) stock?
The outstanding short interest for CERIBELL INC (CBLL) is 4.49% of its float. Check the ownership tab for more information on the CBLL short interest.
CBLL Technical Analysis
CBLL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CBLL. The financial health of CBLL is average, but there are quite some concerns on its profitability.
CBLL Financial Highlights
Over the last trailing twelve months CBLL reported a non-GAAP Earnings per Share(EPS) of -2.99. The EPS decreased by -30.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -23.79% | ||
| ROE | -28.7% | ||
| Debt/Equity | 0.11 |
CBLL Forecast & Estimates
13 analysts have analysed CBLL and the average price target is 32.44 USD. This implies a price increase of 174.18% is expected in the next year compared to the current price of 11.83.
For the next year, analysts expect an EPS growth of 29.38% and a revenue growth 34.92% for CBLL